학술논문
A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16-02 trial
Document Type
Article
Author
Source
In: British Journal of Haematology . (British Journal of Haematology, August 2021, 194(3):580-586)
Subject
Language
English
ISSN
13652141
00071048
00071048